, a significant improvement of NAFLD biomarkers (alanine aminotransferase-ALT, aspartate aminotransferase-AST, gamma-glutamyl transferase-γ-GT and alkaline phosphatase-ALP) as well as liver fibrosis biomarkers (hyaluronic acid-HA, type III precollagen-PC III and type IV collagen-IV-C) was shown in patients with T2DM [114]. This evidence concerns the gene GPT and type 2 diabetes mellitus.